Low-density lipoprotein cholesterol reduction with evolocumab and its use in clinical practice: evidence from swedish national register data
Event:
ESC Congress 2022
Topic:
Lipid-Lowering Agents
Session:
Lipid-lowering by PCSK9 modulation: what’s new?
